Safety, tolerability, pharmacokinetics, and immunogenicity of a human monoclonal antibody targeting the G glycoprotein of henipaviruses in healthy adults: a first-in-human, randomised, controlled, phase 1 study
Playford, Elliott Geoffrey, Munro, Trent, Mahler, Stephen M, Elliott, Suzanne, Gerometta, Michael, Hoger, Kym L, Jones, Martina L, Griffin, Paul, Lynch, Kathleen D, Carroll, Heidi, El Saadi, Debra, Gilmour, Margaret E, Hughes, Benjamin, Hughes, Karen, Huang, Edwin, de Bakker, Christopher, Klein, Reuben, Scher, Mark G, Smith, Ina L, Wang, Lin-Fa, Lambert, Stephen B, Dimitrov, Dimiter S, Gray, Peter P, Broder, Christopher C
Published in The Lancet infectious diseases (01.04.2020)
Published in The Lancet infectious diseases (01.04.2020)
Get full text
Journal Article